NCT05907681 Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M)
| NCT ID | NCT05907681 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Samsung Medical Center |
| Condition | Breast Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2023-05-11 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2023-05-11 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a prospective observational study on outcomes of high precision hypo-fractionated radiotherapy in breast cancer with distant metastasis.
Eligibility Criteria
Inclusion Criteria: * histologically confirmed breast cancer * presence of distant metastasis * radiation therapy using IMRT, SBRT, or proton therapy is done or planned * Able and willing to comply with the study protocol Exclusion Criteria: * unable to adhere to the study protocol
Contact & Investigator
Haeyoung Kim
PRINCIPAL INVESTIGATOR
Samsung Medical Center
Frequently Asked Questions
Who can join the NCT05907681 clinical trial?
This trial is open to female participants only, aged 19 Years or older, up to 100 Years, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05907681 currently recruiting?
Yes, NCT05907681 is actively recruiting participants. Contact the research team at haeyoung0131.kim@samsung.com for enrollment information.
Where is the NCT05907681 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT05907681 clinical trial?
NCT05907681 is sponsored by Samsung Medical Center. The principal investigator is Haeyoung Kim at Samsung Medical Center. The trial plans to enroll 400 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.